Tag: Barry S. Ticho
Stokes’ STK-001 secures FDA orphan drug designation for Dravet Syndrome
US biotech company Stoke Therapeutics has secured orphan drug designation for its lead product candidate - STK-001 from the US Food and Drug Administration (FDA) ... Read More